Allgemein

New Novodiag® Stool Parasites Test Allows Rapid, Accurate and Cost-effective Molecular Testing for Gastrointestinal Infections

ESPOO, Finland–(BUSINESS WIRE)–#AMR–Mobidiag Ltd., a revenue generating, molecular diagnostics company with complementary platforms that address antimicrobial resistance and other areas of unmet diagnostic need, today announces the CE-IVD marking of the Novodiag® Stool Parasites test, a comprehensive and cost-effective molecular diagnostic test for the detection of intestinal parasites directly from stool samples. Tuomas Tenkanen, CEO … [Read more…]

LEO Pharma to Highlight Data at 28th Congress of the European Academy of Dermatology (EADV)

Data will communicate new and updated findings, including in the treatment of psoriasis, atopic dermatitis and chronic hand eczema BALLERUP, Denmark–(BUSINESS WIRE)–LEO Pharma A/S, a global leader in medical dermatology, today announced that data from company-sponsored, health economic outcome and investigator-initiated studies will be presented at the 28th annual Congress of the European Academy of … [Read more…]

Samsung Bioepis Presents Real-world Data of BENEPALI™ (etanercept) in Patients with Psoriasis at European Academy of Dermatology and Venereology (EADV) Congress

Real-world data from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) shows that BENEPALI™ is effective in patients with psoriasis   INCHEON, Korea–(BUSINESS WIRE)–Samsung Bioepis Co., Ltd. today announced real-world data of BENEPALI™ in patients with moderate to severe psoriasis from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR). The results … [Read more…]

GenSight Biologics Reports Evidence of GS010 DNA Transfer to Contralateral Eye of Primates Unilaterally Injected With GS010 Gene Therapy

First study to find direct evidence that therapeutic gene is transferred from the injected eye to the uninjected contralateral eye of primates Findings support mechanism for bilateral visual improvement with unilateral GS010 gene therapy, which was consistently observed in LHON subjects in the REVERSE and RESCUE Phase III trials PARIS–(BUSINESS WIRE)–Regulatory News: GenSight Biologics (Euronext: … [Read more…]

Novigenix Receives Reimbursement Coverage for Colox® in Switzerland

First liquid biopsy test reimbursed in Switzerland for colon cancer screening through private outpatient supplementary insurance product offered by Helsana LAUSANNE, Switzerland–(BUSINESS WIRE)–Novigenix SA, a leading Immuno-Transcriptomics company that develops and commercializes solutions for early cancer detection and precision medicine. today announced that Helsana, the leading health insurance provider in Switzerland, has started coverage for … [Read more…]